Soa Wealth Advisors, Llc. Mirati Therapeutics, Inc. Transaction History

Soa Wealth Advisors, Llc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 07, 2022	BUY	$59.5 - $86.7 $47,659 - $69,446	801 New	801 $55,000
Q2 2022 Jul 13, 2022	SELL	$39.16 - $88.71 $31,367 - $71,056	-801 Closed	0 $0
Q1 2022 Apr 07, 2022	BUY	$75.82 - $150.97 $30,403 - $60,538	401 Added 100.25%	801 $65,000
Q4 2021 Jan 13, 2022	SELL	$132.01 - $190.29 $52,936 - $76,306	-401 Reduced 50.06%	400 $59,000
Q4 2020 Mar 10, 2021	BUY	$162.05 - $240.27 $129,802 - $192,456	801 New	801 $164,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Soa Wealth Advisors, Llc., based on Form 13F filings with the SEC.

Stay updated on Soa Wealth Advisors, Llc. with notifications on news.